SMC rejects bempedoic acid for primary hypercholesterolaemia or mixed dyslipidaemia

The submitting company did not present sufficiently robust clinical and economic analyses to gain acceptance says the SMC.

Join OnMedica and benefit from:

  • Bitesize CPD and easy to digest content, free for UK-based GPs and specialist doctors
  • High-quality, evidence-based content developed by expert editors and clinicians
  • Articles, quizzes, videos, visual summaries and more
  • Regulatory alerts and round-up of medical journals
  • New content added daily, so you know you’re always up to date

Existing members Sign in